Profile data is unavailable for this security.
About the company
NANG KUANG PHARMACEUTICAL CO., LTD. is principally engaged in the manufacture, processing and trading of western medicine. The company main products include injections, sterile injections, powder injections, hard capsules, bare ingots, film ingots, casing ingots, granules and creams, among others. The Company is also engaged in the manufacture, processing and trading of medical equipment. The Company distributes its products within the domestic market and to overseas markets.
- Revenue in TWD (TTM)2.09bn
- Net income in TWD110.65m
- Incorporated1973
- Employees552.00
- LocationNang Kuang Pharmaceutical Co LtdNo.1001, Zhongshan Road, Xinhua DistrictTAINAN 712TaiwanTWN
- Phone+886 65984121
- Fax+886 65981845
- Websitehttps://www.nangkuang.com.tw/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chunghwa Chemical Synthsis&Biotech CoLtd | 1.51bn | 117.69m | 3.17bn | 243.00 | 27.03 | 0.9477 | 10.23 | 2.10 | 1.51 | 1.51 | 19.37 | 43.16 | 0.3039 | 1.02 | 5.27 | -- | 2.37 | 9.03 | 2.73 | 10.56 | 32.33 | 43.26 | 7.81 | 20.15 | 0.7205 | -- | 0.2315 | 24.83 | -1.45 | 15.40 | -43.14 | 2.49 | 36.95 | -7.79 |
| Phytohealth Corp | 163.13m | -86.82m | 3.30bn | 84.00 | -- | 1.71 | -- | 20.21 | -0.4371 | -0.4371 | 0.8213 | 9.72 | 0.0679 | 0.6269 | 4.19 | -- | -5.15 | -5.66 | -6.35 | -7.31 | 39.92 | 47.70 | -75.82 | -92.91 | 31.96 | -- | 0.0088 | -- | 19.95 | 8.62 | 40.67 | -- | -40.76 | -- |
| Nang Kuang Pharmaceutical Co Ltd | 2.09bn | 110.65m | 4.35bn | 552.00 | 39.34 | 1.91 | 14.85 | 2.08 | 1.09 | 1.09 | 20.72 | 22.52 | 0.571 | 1.89 | 8.07 | -- | 3.02 | 6.75 | 4.47 | 9.64 | 33.14 | 34.77 | 5.28 | 12.22 | 0.6312 | 14.42 | 0.1587 | 82.74 | 10.81 | 6.92 | -43.63 | 14.41 | 19.51 | 10.76 |
| Sinphar Pharmaceutical Co Ltd | 3.01bn | 361.33m | 5.52bn | 984.00 | 14.18 | 1.64 | 9.38 | 1.83 | 2.15 | 2.15 | 17.93 | 18.61 | 0.4864 | 2.28 | 6.06 | -- | 5.71 | -0.0147 | 7.67 | -0.0203 | 39.02 | 37.49 | 11.74 | -0.0344 | 1.44 | 37.22 | 0.3599 | 79.70 | 3.72 | 5.98 | 67.01 | 111.88 | 3.31 | 58.49 |
| Cenra Inc | 8.87bn | 355.20m | 5.58bn | 1.40k | 31.45 | 1.50 | 7.96 | 0.6292 | 1.19 | 1.19 | 29.73 | 24.90 | 0.7027 | 2.22 | 5.63 | -- | 2.83 | 3.69 | 4.03 | 4.96 | 36.79 | 36.56 | 4.02 | 5.50 | 0.7959 | -- | 0.2943 | 52.77 | 1.40 | 2.50 | -32.51 | -2.72 | 3.57 | -8.97 |
Data as of Nov 14 2024. Currency figures normalised to Nang Kuang Pharmaceutical Co Ltd's reporting currency: Taiwan Dollar TWD
1.34%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 1.24m | 1.23% |
| American Century Investment Management, Inc.as of 03 Oct 2024 | 79.00k | 0.08% |
| Dimensional Fund Advisors Ltd.as of 31 Jul 2024 | 28.12k | 0.03% |
| DFA Australia Ltd.as of 30 Sep 2024 | 3.43k | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
